Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
or

Haemonetics Corp (HAE)

Haemonetics Corp (HAE)
24.90 x 1 99.07 x 2
Pre-market by (Cboe BZX)
61.92 +1.58 (+2.62%) 04/24/25 [NYSE]
24.90 x 1 99.07 x 2
Pre-market 61.92 unch (unch) 19:00 ET
Profile for Thu, Apr 24th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.

Company Info

Haemonetics Corp 125 Summer Street Boston MA 02110 USA

www.haemonetics.com Employees: 3,657 P: 781-848-7100 F: 781-356-9956

Sector:

Medical

Description:

Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management.

Key Statistics

Overview:

Market Capitalization, $K 3,110,675
Enterprise Value, $K 3,729,435
Shares Outstanding, K 50,237
Annual Sales, $ 1,309 M
Annual Net Income, $ 117,560 K
Last Quarter Sales, $ 348,540 K
Last Quarter Net Income, $ 37,490 K
EBIT, $ 225,820 K
EBITDA, $ 329,560 K
60-Month Beta 0.41
% of Insider Shareholders 1.80%
% of Institutional Shareholders 99.67%
Float, K 49,333
% Float 98.20%
Short Volume Ratio 0.46

Growth:

1-Year Return -28.18%
3-Year Return 22.20%
5-Year Return -44.33%
5-Year Revenue Growth 35.29%
5-Year Earnings Growth 65.69%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.19 on 02/06/25
Next Earnings Date 05/08/25 [BMO]
Earnings Per Share ttm 4.23
EPS Growth vs. Prev Qtr 6.25%
EPS Growth vs. Prev Year 14.42%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 2-1 on 12/03/12

HAE Ratios

Ratio
Price/Earnings ttm 14.26
Price/Earnings forward 11.87
Price/Earnings to Growth 0.94
Return-on-Equity % 23.66%
Return-on-Assets % 8.82%
Profit Margin % 8.98%
Debt/Equity 1.35
Price/Sales 2.31
Price/Cash Flow 9.77
Price/Book 3.28
Book Value/Share 18.06
Interest Coverage 12.66
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective